| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.19 | 0.0004 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |